A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene

NCT04123626 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Autosomal Dominant Retinitis Pigmentosa
Eye Diseases
Eye Diseases, Hereditary
Retinal Dystrophies
Retinal Disease
Retinitis
Vision Tunnel
Vision Disorders

Interventions

DRUG: QR-1123
OTHER: Sham procedure

Sponsor

ProQR Therapeutics